Another potential opportunity is available with the impending price changes for Zarator in the Pharmaceutical Schedule from 1 November 2016.

Pfizer are not reducing their pricing to match the reference pricing level and have taken the opportunity to supply in line with private market. As they are not meeting the Schedule price there will be a patient surcharge applied.

This gives you an opportunity to purchase now and make additional margin either now or after 1 November 2016.

The following changes are ex manufacturer pricing and all effective 1 November 2016.

Zarator Tab 10 mg 90 currently $2.52 moving to $6.50

Zarator Tab 20 mg 90 currently $4.17 moving to $6.50

Zarator Tab 40 mg 90 have reduced to $6.50 from $7.32 (NOW)

Zarator Tab 80 mg 90 have reduced to $6.50 from $16.23 (NOW)

You have opportunities in both price decreases and price increases. Then there is the potential of the private market or patients willing to pay the surcharge to stay on the medication they are familiar with. Your call and there is no pressure from us. We are simply the conveyers of opportunity.

Please be aware we will not accept Zarator back for credit

About The Author